Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Jun;41(6):1312-1320.
doi: 10.2337/dc17-2010.

Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis

Affiliations
Meta-Analysis

Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis

Lee Ling Lim et al. Diabetes Care. 2018 Jun.

Abstract

Objective: The implementation of the Chronic Care Model (CCM) improves health care quality. We examined the sustained effectiveness of multicomponent integrated care in type 2 diabetes.

Research design and methods: We searched PubMed and Ovid MEDLINE (January 2000-August 2016) and identified randomized controlled trials comprising two or more quality improvement strategies from two or more domains (health system, health care providers, or patients) lasting ≥12 months with one or more clinical outcomes. Two reviewers extracted data and appraised the reporting quality.

Results: In a meta-analysis of 181 trials (N = 135,112), random-effects modeling revealed pooled mean differences in HbA1c of -0.28% (95% CI -0.35 to -0.21) (-3.1 mmol/mol [-3.9 to -2.3]), in systolic blood pressure (SBP) of -2.3 mmHg (-3.1 to -1.4), in diastolic blood pressure (DBP) of -1.1 mmHg (-1.5 to -0.6), and in LDL cholesterol (LDL-C) of -0.14 mmol/L (-0.21 to -0.07), with greater effects in patients with LDL-C ≥3.4 mmol/L (-0.31 vs. -0.10 mmol/L for <3.4 mmol/L; Pdifference = 0.013), studies from Asia (HbA1c -0.51% vs. -0.23% for North America [-5.5 vs. -2.5 mmol/mol]; Pdifference = 0.046), and studies lasting >12 months (SBP -3.4 vs. -1.4 mmHg, Pdifference = 0.034; DBP -1.7 vs. -0.7 mmHg, Pdifference = 0.047; LDL-C -0.21 vs. -0.07 mmol/L for 12-month studies, Pdifference = 0.049). Patients with median age <60 years had greater HbA1c reduction (-0.35% vs. -0.18% for ≥60 years [-3.8 vs. -2.0 mmol/mol]; Pdifference = 0.029). Team change, patient education/self-management, and improved patient-provider communication had the largest effect sizes (0.28-0.36% [3.0-3.9 mmol/mol]).

Conclusions: Despite the small effect size of multicomponent integrated care (in part attenuated by good background care), team-based care with better information flow may improve patient-provider communication and self-management in patients who are young, with suboptimal control, and in low-resource settings.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Meta-analyses results of the effects of multicomponent integrated care on HbA1c (%) (A), HbA1c (mmol/mol) (B), SBP (mmHg) (C), DBP (mmHg) (D), and LDL-C (mmol/L) (E), stratified by different levels of baseline cardiometabolic control and geographic regions. To convert LDL-C to mg/dL, multiply by 38.67. MD, mean difference; N, number of trials with analyzable data.
Figure 2
Figure 2
Meta-analyses results of the effects of individual QI strategies on HbA1c (%) (A), HbA1c (mmol/mol) (B), SBP (mmHg) (C), DBP (mmHg) (D), and LDL-C (mmol/L) (E). To convert LDL-C to mg/dL, multiply by 38.67. MD, mean difference; N, number of trials with analyzable data.

References

    1. International Diabetes Federation. IDF Diabetes Atlas, 8th edition [Internet]. Brussels, Belgium, International Diabetes Federation, 2017. Available from http://www.diabetesatlas.org. Accessed 15 December 2017
    1. NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016;387:1513–1530 - PMC - PubMed
    1. Bommer C, Heesemann E, Sagalova V, et al. . The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol 2017;5:423–430 - PubMed
    1. International Diabetes Federation Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes [Internet]. Brussels, Belgium, International Diabetes Federation, 2012. Available from https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-.... Accessed 5 April 2017
    1. American Diabetes Association 3. Comprehensive medical evaluation and assessment of comorbidities: Standards of Medical Care in Diabetes—2018. Diabetes Care 2018;41(Suppl. 1):S28–S37 - PubMed

Publication types